These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of the NuVasive and Nevro businesses and our ability to successfully integrate and ...

and had been linked to a possible $3 billion takeover of spinal surgery company NuVasive last month which thus far hasn’t come to fruition. Commenting on the Osiris deal, Nawana said it would ...

The company also returned to debt-free status after paying off the rest of the $450 million debt from its NuVasive merger.6. Globus Medical’s board of directors authorized a share repurchase program ...

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 million. The repurchase includes the Audobon, Pennsylvania-based orthoped ...

Visit a quote page and your recently viewed tickers will be displayed here.